Ultragenyx Pharmaceutical Inc. Files 8-K

Ticker: RARE · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1515673

Ultragenyx Pharmaceutical Inc. 8-K Filing Summary
FieldDetail
CompanyUltragenyx Pharmaceutical Inc. (RARE)
Form Type8-K
Filed DateJul 31, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, corporate-filing

Related Tickers: UGNX

TL;DR

UGNX filed an 8-K on 7/31. Details on the 'other event' TBD.

AI Summary

Ultragenyx Pharmaceutical Inc. filed an 8-K on July 31, 2025, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms the company's reporting status and basic corporate information. The company is incorporated in Delaware and headquartered in Novato, California.

Why It Matters

This filing indicates a material event has occurred for Ultragenyx Pharmaceutical Inc. that requires disclosure to the public, though the specific nature of the event is not detailed in the provided text.

Risk Assessment

Risk Level: low — The filing is a standard corporate disclosure and does not contain information that inherently poses a risk.

Key Numbers

  • 001-36276 — SEC File Number (Identifies the company's filing with the SEC.)
  • 27-2546083 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • Ultragenyx Pharmaceutical Inc. (company) — Registrant
  • July 31, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 60 Leveroni Court, Novato, California 94949 (address) — Principal Executive Offices
  • 415 483-8800 (phone_number) — Registrant's Telephone Number

FAQ

What specific event is Ultragenyx Pharmaceutical Inc. reporting on July 31, 2025?

The provided text of the 8-K filing does not specify the nature of the 'Other Event' being reported.

Where is Ultragenyx Pharmaceutical Inc.'s principal executive office located?

Ultragenyx Pharmaceutical Inc.'s principal executive offices are located at 60 Leveroni Court, Novato, California 94949.

What is the SEC file number for Ultragenyx Pharmaceutical Inc.?

The SEC file number for Ultragenyx Pharmaceutical Inc. is 001-36276.

In which state was Ultragenyx Pharmaceutical Inc. incorporated?

Ultragenyx Pharmaceutical Inc. was incorporated in Delaware.

What is the telephone number for Ultragenyx Pharmaceutical Inc.?

The telephone number for Ultragenyx Pharmaceutical Inc., including area code, is 415 483-8800.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding Ultragenyx Pharmaceutical Inc. (RARE).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.